Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plazomicin vs Colistin for CRE Infections (CARE)
NCT01970371Phase 3Completed
- Sponsor
- Achaogen, Inc.
- Start
- Sep 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of plazomicin in bloodstream infection (BSI), hospital-acquired bacterial pneumonia (HAP), ventilator-associated pneumonia (VAP), complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Achaogen, Inc.. Started Sep 2014; status: completed.
02
Drugs
plazomicin
03
Conditions
bloodstream infection (BSI)hospital-acquired bacterial pneumonia (HAP)ventilator-associated pneumonia (VAP)complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT01970371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970371.